tirzepatide and warfarin An Observational Study of Cardiovascular Outcomes of vs Glucagon-Like Peptide-1 Receptor Agonists When New Therapies Meet Old

Favorable shifts were also observed in non-invasive assessments, including the enhanced liver fibrosis score, vibration-controlled transient elastography, N-terminal type III Collagen Propeptide (PRO-C3), FibroScan-AST (FAST) score, and aminotransferases

People with serious gastrointestinal conditions, like gastroparesis or uncontrolled inflammatory bowel disease, should not take GLP-1 medications

Most patients take 20 weeks to reach the 15mg maintenance dose

Variants in GLP1R, GIPR, FTO, and MC4R may help provide context for how your body regulates appetite, glucose, and weight

If side effects persist beyond 2 weeks at a stable dose, your clinician may delay the next increase or maintain your current dose longer

Of course, a case series and mouse studies alone cant tell you how common hyposalivation may be with taking Ozempic, Wegovy, Zepbound, Mounjaro or other such medications